Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.

@article{Mazzone2010IntensiveGL,
  title={Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.},
  author={Theodore Mazzone},
  journal={Circulation},
  year={2010},
  volume={122 21},
  pages={
          2201-11
        }
}
Cardiovascular disease (CVD) is a very common, if not the most common, cause of morbidity and mortality in developed countries, and there has been longstanding recognition that diabetes is a potent risk factor for CVD.1,–,3 Individuals with either type 1 or type 2 diabetes mellitus manifest CVD rates up to 4 to 10 times higher than those observed in nondiabetic subjects. Subjects with diabetes also have been shown to have more advanced atherosclerosis, as measured by carotid intima-media… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 31 CITATIONS

Diabetes and cardiovascular disease.

  • Critical care nursing clinics of North America
  • 2011
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Diagnostic approaches for diabetic cardiomyopathy

  • Cardiovascular Diabetology
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 71 REFERENCES

C - reactive protein and coronary disease : is there a causal link ?

T Koike, S Kitajima, +9 authors J Fan
  • Circulation
  • 2009

C - reactive protein as a risk factor for coronary heart disease : a systematic review and meta - analyses for the U . S . Preventive Services Task Force

J Danesh, MB Pepys
  • Ann Intern Med
  • 2009